Eratia

Medicinal product

(Invented) name

Eratia

Active substance (s)

Piperacilinas/Tazobaktamas

Strength

2000 mg/250 mg

Pharmaceutical form

milteliai infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01CR05, Piperacillin and beta-lactamase inhibitor

Marketing authorisation holder

Medochemie Ltd., Kipras

Date of authorisation

2024-04-24

Date of renewal

Documents

5412 Eratia PCS PL 2024 10 17.docx

5412 Pakuotės lapelis 2024 10 17.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

NL/H/5451/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Flakone yra:	1 vg
Piperacilinas	2000 mg
Tazobaktamas	250 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
113467	99585	1099585	flakonas	N1		Receptinis	LT/1/24/5412/001	Netiekiama	-	-	No	-	-
113468	99586	1099586	flakonas	N10		Receptinis	LT/1/24/5412/002	Netiekiama	-	2025-12-01	No	-	-

Stadijos

Data	Stadija
2024-04-24	Registruotas